- RFK Jr.’s vaccine committee advises Merck’s RSV shot for babies NewsNation
- RFK Jr’s vaccine panel recommends new RSV treatment for infants The Guardian
- ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season Merck.com
- CDC vaccine advisory panel to study child immunization schedule, recommends RSV shot for babies ABC News – Breaking News, Latest News and Videos
- New CDC vaccine advisers vote to recommend Merck RSV antibody protection for babies CNN